Solid Biosciences Inc. SLDB Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s operating cash flow?
- Solid Biosciences Inc. (SLDB) reported operating cash flow of -$47.23M in Q1 2026.
- How has Solid Biosciences Inc.'s operating cash flow changed year-over-year?
- Solid Biosciences Inc.'s operating cash flow decreased by 48.3% year-over-year, from -$31.85M to -$47.23M.
- What is the long-term trend for Solid Biosciences Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s operating cash flow has grown at a 19.1% compound annual growth rate (CAGR), from -$77.76M to -$156.29M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.